CLINICAL STUDY: CONGESTIVE HEART FAILURE
Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy
Andrea Rossi, MD*,*,
Mariantonietta Cicoira, MD*,
Luisa Zanolla, MD*,
Rita Sandrini, MD*,
Giorgio Golia, MD*,
Piero Zardini, MD* and
Maurice Enriquez-Sarano, MD, FACC
* Dipartimento di Scienze Biomediche e Chirurgiche, Sezione di Cardiologia, Universita di Verona, Verona, Italy
Division of Cardiovascular Disease, Mayo Clinic, Rochester, Minnesota, USA
Manuscript received February 4, 2002;
revised manuscript received April 30, 2002,
accepted June 7, 2002.
* Reprint requests and correspondence: Dr. Andrea Rossi, Divisione Clinicizzata di Cardiologia, Ospedale Maggiore, P.le Stefani 1, 37126 Verona, Italy. andrea.rossi{at}univr.it
OBJECTIVES: We aimed to investigate the determinants of left atrial (LA) volume and its prognostic value in patients with dilated cardiomyopathy (DCM).
BACKGROUND: Enlargement of the LA is a marker of mortality in the general population. Patients with DCM are characterized by a wide range of LA sizes, but the clinical role of this observation has been played down.
METHODS: A complete echocardiographic Doppler examination was performed in 337 patients (age 60 ± 13 years; 84% male) with the diagnosis of DCM. Left atrial maximal volume (LAmax) was measured at left ventricular (LV) end systole (four-chamber view; arealength method). Left ventricular end-diastolic and end-systolic volumes (LVEDV and LVESV) and ejection fraction (EF) were also measured. Mitral regurgitation (MR) was graded using a 5-point scale. Mitral E-wave (E) and A-wave (A) velocities, as well as their ratio (E/A), were measured off-line.
RESULTS: Determinants of LAmax were: atrial fibrillation (r = 0.34, p < 0.0001), LVEDV (r = 0.46, p < 0.0001), EF (r = 0.40, p < 0.0001), MR (r = 0.39, p < 0.0001), and E/A ratio (r = 0.36, p < 0.0001). During follow-up (41 ± 29 months), 77 patients died and 12 underwent heart transplantation. Univariate Cox analysis showed that LAmax (hazard ratio [HR] 1.01, 95% confidence interval [CI] 1.0071.013, p < 0.0001), LVESV (HR 1.003, CI 1.0011.005, p = 0.0003), E/A ratio (HR 1.6, CI 1.32.005, p < 0.0001), and MR (HR 1.21, CI 1.031.44, p = 0.02) were related to the outcome. On bivariate Cox analysis, LAmax predicted the prognosis independently of each determinant. Patients with a larger LA volume (LAmax/m2 >68.5 ml/m2) had a risk ratio of 3.8 compared with those with a smaller LA volume.
CONCLUSIONS: In patients with DCM, LA volume is associated with LV remodeling, diastolic dysfunction, and the degree of MR. The maximal volume of the LA has an independent and incremental prognostic value, compared with all its determinants.
|
Abbreviations and Acronyms
| | AF | | atrial fibrillation | | CI | | confidence interval | | DCM | | dilated cardiomyopathy | | EF | | ejection fraction | | HR | | hazard ratio | | LA | | left atrium/atrial | | LV | | left ventricle/ventricular | | LVEDV and LVESV | | left ventricular end-diastolic and end-systolic volume, respectively | | MR | | mitral regurgitation | | ROC | | receiver-operating characteristic |
|
This article has been cited by other articles:

|
 |

|
 |
 
M. Kubanek, K. M. Goode, V. Lanska, A. L. Clark, and J. G.F. Cleland
The prognostic value of repeated measurement of N-terminal pro-B-type natriuretic peptide in patients with chronic heart failure due to left ventricular systolic dysfunction
Eur J Heart Fail,
April 1, 2009;
11(4):
367 - 377.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Meta-analysis Research Group in Echocardiography (
Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: An individual patient meta-analysis
Eur J Heart Fail,
August 1, 2008;
10(8):
786 - 792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Whalley, S. P. Wright, A. Pearl, G. D. Gamble, H. J. Walsh, M. Richards, and R. N. Doughty
Prognostic role of echocardiography and brain natriuretic peptide in symptomatic breathless patients in the community
Eur. Heart J.,
February 2, 2008;
29(4):
509 - 516.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Enriquez-Sarano, V. T. Nkomo, and H. Michelena
Principles and Practice of Echocardiography in Cardiac Surgery
Card. Surg. Adult,
January 1, 2008;
3(2008):
315 - 348.
[Full Text]
|
 |
|

|
 |

|
 |
 
D. Messika-Zeitoun, M. Bellamy, J.-F. Avierinos, J. Breen, C. Eusemann, A. Rossi, T. Behrenbeck, C. Scott, J. A. Tajik, and M. Enriquez-Sarano
Left atrial remodelling in mitral regurgitation--methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study
Eur. Heart J.,
July 2, 2007;
28(14):
1773 - 1781.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C Lofiego, E Biagini, F Pasquale, M Ferlito, G Rocchi, E Perugini, L Bacchi-Reggiani, G Boriani, O Leone, K Caliskan, et al.
Wide spectrum of presentation and variable outcomes of isolated left ventricular non-compaction
Heart,
January 1, 2007;
93(1):
65 - 71.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. P. Abhayaratna, J. B. Seward, C. P. Appleton, P. S. Douglas, J. K. Oh, A. J. Tajik, and T. S.M. Tsang
Left Atrial Size: Physiologic Determinants and Clinical Applications
J. Am. Coll. Cardiol.,
June 20, 2006;
47(12):
2357 - 2363.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S.M. Tsang, W. P. Abhayaratna, M. E. Barnes, Y. Miyasaka, B. J. Gersh, K. R. Bailey, S. S. Cha, and J. B. Seward
Prediction of Cardiovascular Outcomes With Left Atrial Size: Is Volume Superior to Area or Diameter?
J. Am. Coll. Cardiol.,
March 7, 2006;
47(5):
1018 - 1023.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Osranek, F. Bursi, K. R. Bailey, B. R. Grossardt, R. D. Brown Jr, S. L. Kopecky, T. S. Tsang, and J. B. Seward
Left atrial volume predicts cardiovascular events in patients originally diagnosed with lone atrial fibrillation: three-decade follow-up
Eur. Heart J.,
December 1, 2005;
26(23):
2556 - 2561.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bollmann
First comes diagnosis then comes treatment: an underappreciated paradigm in atrial fibrillation management
Eur. Heart J.,
December 1, 2005;
26(23):
2487 - 2489.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Kernis, V. T. Nkomo, D. Messika-Zeitoun, B. J. Gersh, T. M. Sundt III, K. V. Ballman, C. G. Scott, H. V. Schaff, and M. Enriquez-Sarano
Atrial Fibrillation After Surgical Correction of Mitral Regurgitation in Sinus Rhythm: Incidence, Outcome, and Determinants
Circulation,
October 19, 2004;
110(16):
2320 - 2325.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. de Groote, J. Dagorn, B. Soudan, N. Lamblin, E. McFadden, and C. Bauters
B-type natriuretic peptide and peak exercise oxygen consumption provide independent information for risk stratification in patients with stable congestive heart failure
J. Am. Coll. Cardiol.,
May 5, 2004;
43(9):
1584 - 1589.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Khan, G. W. Moe, N. Nili, E. Rezaei, M. Eskandarian, J. Butany, and B. H. Strauss
The cardiac atria are chambers of active remodeling and dynamic collagen turnover during evolving heart failure
J. Am. Coll. Cardiol.,
January 7, 2004;
43(1):
68 - 76.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|